Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration-resistant prostate cancer.
Yang T, Liu Y, Chen S, Tian J, Zhu X, Zhang L, Wang W, Qin Y, Richter J, Anand A, Xu C, Chi Y, Wang C, Bian C, Wu D, Li Z, Huang S.
Yang T, et al. Among authors: wang w, wang c.
Prostate. 2022 Sep;82(13):1284-1292. doi: 10.1002/pros.24402. Epub 2022 Jun 23.
Prostate. 2022.
PMID: 35747943